EUVIMEDEUVIMED entdecken
Crossref

Leveraging deep learning and structure-based drug repurposing for the discovery of potent Trk-A inhibitors targeting CIPA

Muhammad Waleed Iqbal, Syed Zeeshan Haider, Xinxiao Sun, Khalid A Al-Ghanim, Muhammad Zohaib Nawaz, Qipeng Yuan

Bioorganic Chemistry · 2025

DOI: 10.1016/j.bioorg.2025.108680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Muhammad Waleed Iqbal und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resources Engineering, Beijing University of Chemical Technology, Beijing 100029, PR China. Hauptthemen laut MEDLINE: Drug Repositioning, Deep Learning, Protein Kinase Inhibitors, Receptor, trkA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Key Technologies Research and Development Program, King Saud University, Beijing University of Chemical Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nerve growth factor receptor Trk-A is essential for neurons' survival, growth, and function. The mutations in its gene can cause a disorder called CIPA, which requires the inhibition of Trk-A for preventing CIPA. Reported inhibitors of Trk-A exhibited challenges related to specificity and selectivity. This study used an integrated deep learning and structure-based drug repurposing approach to identify novel, potent, and non-toxic Trk-A inhibitors. Deep learning-based artificial neural network (ANN) models were trained and tested based on Trk-A targeting compounds' already existing bioactivity data. The trained ANN models were assessed for their performance, and a reliable model was employed to screen highly potent compounds from the FDA-approved drugs library. The screened drugs were further evaluated using molecular docking and identified gonadoliberin, caerulein, anidulafungin, and micafungin as potential Trk-A inhibitors. Molecular simulation analysis, including RMSD, RMSF, Rg, H-bonds, PCA, and MMGBSA/MMPBSA, further confirmed the stability of the selected drugs with Trk-A.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningDeep LearningProtein Kinase InhibitorsReceptor, trkADrug DiscoveryHumansStructure-Activity RelationshipMolecular StructureMolecular Docking SimulationDose-Response Relationship, Drug

Stichwörter der Autor:innen

Artificial neural networkCIPADeep learningMolecular docking and simulationTrk-A

Substanzen

Protein Kinase InhibitorsReceptor, trkANTRK1 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Chemical Resources Engineering, Beijing University of Chemical Technology, Beijing 100029, PR China.
  • International Joint Laboratory on Synthetic Biology and Biomass Biorefinery, Biofuels Institute, School of Emergency Management, School of the Environment and Safety Engineering, Jiangsu University, Zhenjiang 212013, Ch…
  • Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
  • State Key Laboratory of Chemical Resources Engineering, Beijing University of Chemical Technology, Beijing 100029, PR China. Electronic address: yuanqp@mail.buct.edu.cn.

Förderung

  • Key Technologies Research and Development Program
  • King Saud University
  • Beijing University of Chemical Technology
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • State Key Laboratory of Chemical Resource Engineering

Zitieren

APA

Iqbal, M. W., Haider, S. Z., Sun, X., Al-Ghanim, K. A., Nawaz, M. Z., & Yuan, Q. (2025). Leveraging deep learning and structure-based drug repurposing for the discovery of potent Trk-A inhibitors targeting CIPA. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108680

Vancouver

Iqbal MW, Haider SZ, Sun X, Al-Ghanim KA, Nawaz MZ, Yuan Q. Leveraging deep learning and structure-based drug repurposing for the discovery of potent Trk-A inhibitors targeting CIPA. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108680

BibTeX
@article{Iqbal2025,
  author = {Iqbal, Muhammad Waleed and Haider, Syed Zeeshan and Sun, Xinxiao and Al-Ghanim, Khalid A and Nawaz, Muhammad Zohaib and Yuan, Qipeng},
  title = {Leveraging deep learning and structure-based drug repurposing for the discovery of potent Trk-A inhibitors targeting CIPA},
  journal = {Bioorganic Chemistry},
  year = {2025},
  doi = {10.1016/j.bioorg.2025.108680}
}
Kostenlos starten →